InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Garland Jonathan Todd. Officer active across 2 companies, notably Cytek Biosciences, Inc.. In total, 3 filings have been published. History available since 6 May 2024. The latest transaction was disclosed on 6 May 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations